Bi-lateral congenital hearing loss is a condition at birth that impair of diminish the

sense of hearing in both ears. Using the widely known 136 standard of universal
newborn hearing screening the condition can be identified and given early
intervention through follow-ups according to 2021 taiwan national statistic out of 941
neonates who fell the unhs in both ears 379 were lost to follow-up. Ducted research
to determine the efficiency and performance of unhs in taiwan

The materials and method used during this study include study design in this national
skilled investigation reach out to children who filled the nhs boat years between 2013
and 2014 through interviewing phones in 2016. This survey was approve and granted
by the health promotion administration with a reference number next are the
participants it stated that were about 200,000 born babies in each years. The
program also aims to reduce the age of identification and intervention of newborn.
Agreement on interventional services for infants born with unilateral hearing loss has
been rich but regular monitoring of the hearing status has been the most popular
approach. Also seeks to identify and treat newborn with bilateral congenital hearing
loss at younger age regardless of the kind of degree of the hearing loss to lessen any
negative side effects that may result. Moreover hearing aids enrollment in auditory
training program and confirmation of hearing status we’re all examine in families
whose children were thought to have congenital bilateral hearing loss with the help
of the study and knowledge gap in previous publication on the follow-up of kids who
received bilateral rafael are from the nhs can be filled.

Newborn screening (NBS) detects newborns who are at risk for congenital
abnormalities and has been found to enhance outcomes when treated early.
Congenital abnormalities are the most common cause of infant death in the United
States. Despite the development of specialized pediatric cardiac centers, critical
congenital heart disease (C-CHD) remains the leading cause of death and morbidity
in developed countries.1,2 C-CHD is defined as congenital heart disease requiring
surgery or catheter intervention in the first year of life and accounts for 25% of CHD.3
Although CHD is the most common form of congenital malformation, occurring in 9
of every 1,000 live births,4 it is not always identified. As a result, regardless of their
pediatric expertise, all cardiac sonographers must be able to detect CHD and
recognize those instances that are critical in nature.The incidence of congenital heart
disease is higher at low elevations, according to evidence from low altitudes. CHD
affects roughly 6–9% of people, with critical CHD affecting 15%–25%. Pulse oximetry,
with a cutoff of 95 percent SpO2, has been recommended as a newborn screening
technique for serious CHD. This screening procedure, however, is ineffective at high
altitude for a variety of reasons. To begin with, babies born at high altitude had lower
equivalent SpO2 and greater standard variations across altitude levels.

References
Otorhinolaryngology volume 157
Www.sciencedirect.com/science/article/pii/S0 1 6 5 5 8 7 6 2 2 0 0 1 0 2 1